The CD8+ T immune cells are known as the major drivers of the anticancer immunity [79] and earlier, CD8+ T immune cells infiltration was utilized as a diagnostic marker for the early detection of laryngeal squamous cell carcinoma abbreviated as LSCC [80]. Here, CD8A is linked to laryngeal squamous cell carcinoma.